首页>
外国专利>
Semlopaline for the prevention of venous thromboembolism in cancer patients undergoing chemotherapy
Semlopaline for the prevention of venous thromboembolism in cancer patients undergoing chemotherapy
展开▼
机译:塞莫帕林预防癌症化疗患者的静脉血栓栓塞
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to an ultra-low molecular weight heparin with an average molecular weight of 2000 to 3000 Daltons, an anti-FXa activity of about 160 U/mg and an anti-FIIa activity of about 2 U/mg, in particular semuloparin, for use as an antithrombotic agent for the prophylaxis of venous thromboembolism in cancer patients receiving chemotherapy for locally advanced or metastatic solid tumors, more specifically in patients receiving chemotherapy for locally advanced or metastatic pancreatic or lung cancer, or for locally advanced or metastatic solid tumors with a VTE risk score equal to or greater than 3.
展开▼